GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Ono Pharmaceutical Co 4528.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,432.5

+3.40%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥515.78bn

FY2017FY2026

Net income

¥69.77bn

FY2017FY2026

Free cash flow

¥130.80bn

FY2017FY2026

Shareholders' equity

¥850.73bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥515.78bn¥486.87bn¥502.67bn¥447.19bn¥361.36bn¥309.28bn¥292.42bn¥288.63bn¥261.84bn¥244.80bn
Gross profit¥374.07bn¥335.47bn¥372.67bn¥334.28bn¥264.91bn¥221.10bn¥210.87bn¥202.77bn¥194.74bn¥177.88bn
Research and development¥147.04bn¥149.87bn¥112.17bn¥95.34bn¥75.88bn¥62.38bn¥66.50bn¥70.01bn¥68.82bn¥57.51bn
Operating income¥103.33bn¥63.38bn¥163.56bn¥152.29bn¥114.91bn¥92.10bn¥79.18bn¥64.76bn¥59.57bn¥59.72bn
Net income¥69.77bn¥50.05bn¥127.98bn¥112.72bn¥80.52bn¥75.42bn¥59.70bn¥51.54bn¥50.28bn¥55.79bn
Diluted earnings per share148.43106.50272.48236.89164.89151.52119.60103.2597.80108.51

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥1.11trn¥1.06trn¥913.67bn¥882.44bn¥739.20bn¥745.43bn¥673.44bn¥655.06bn¥609.23bn¥617.46bn
Cash and short-term investments¥237.11bn¥210.38bn¥204.59bn¥164.29bn¥116.97bn¥104.97bn¥100.42bn¥71.47bn¥85.78bn¥164.70bn
Total liabilities¥249.87bn¥275.84bn¥115.06bn¥134.62bn¥77.53bn¥105.68bn¥105.42bn¥92.32bn¥79.61bn¥93.25bn
Debt—¥146.68bn¥8.86bn¥9.17bn¥8.80bn¥9.05bn¥8.36bn¥2.20bn¥712.0m¥977.0m
Shareholders' equity¥850.73bn¥782.45bn¥792.96bn¥741.87bn¥655.91bn¥634.13bn¥562.48bn¥557.35bn¥524.39bn¥519.11bn
Shares outstanding470m470m470m476m488m498m499m499m514m514m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥136.82bn¥82.46bn¥110.66bn¥159.61bn¥61.83bn¥73.98bn¥74.16bn¥66.77bn¥15.73bn¥74.45bn
Capital spending−¥6.02bn−¥5.43bn−¥4.02bn−¥14.50bn−¥12.28bn−¥20.29bn−¥22.45bn−¥22.30bn−¥15.62bn−¥14.80bn
Free cash flow¥130.80bn¥77.03bn¥106.64bn¥145.11bn¥49.55bn¥53.68bn¥51.71bn¥44.47bn¥107.0m¥59.65bn
Dividends paid−¥37.53bn−¥37.52bn−¥37.18bn−¥29.74bn−¥27.67bn−¥22.45bn−¥22.77bn−¥21.83bn−¥23.41bn−¥20.12bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥116.16bn¥118.75bn¥139.90bn¥129.60bn¥127.54bn¥112.31bn¥134.22bn¥122.66bn
Gross profit¥87.48bn¥85.69bn¥103.22bn¥94.64bn¥90.52bn¥67.07bn¥88.39bn¥95.46bn
Operating income¥31.18bn¥12.41bn¥37.96bn¥29.78bn¥23.18bn−¥7.65bn¥14.80bn¥24.97bn
Net income¥24.15bn¥818.0m¥28.86bn¥22.50bn¥17.59bn−¥6.54bn¥14.94bn¥16.86bn
Diluted earnings per share51.381.7461.4247.8837.43-13.9331.8135.90
Cash from operations¥1.05bn¥50.18bn¥32.08bn¥51.19bn¥3.37bn¥39.00bn¥8.74bn¥33.91bn
Capital spending−¥1.99bn−¥1.08bn−¥1.90bn−¥1.66bn−¥2.25bn−¥1.42bn−¥1.20bn−¥1.26bn
Free cash flow−¥936.0m¥49.11bn¥30.18bn¥49.53bn¥1.12bn¥37.58bn¥7.54bn¥32.65bn
Total assets¥1.08trn¥1.11trn¥1.08trn¥1.06trn¥1.02trn¥1.06trn¥1.08trn¥1.05trn
Cash and short-term investments¥221.20bn¥237.11bn¥189.27bn¥182.93bn¥139.98bn¥210.38bn¥172.13bn¥181.13bn
Debt¥42.31bn¥113.47bn¥34.36bn¥32.83bn¥32.86bn¥138.18bn¥33.01bn¥152.87bn
Shareholders' equity¥866.83bn¥850.73bn¥839.67bn¥806.35bn¥772.64bn¥782.45bn¥815.92bn¥782.46bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.9%10.8%12.4%
Operating income-12.1%2.3%13.2%
Net income-14.8%-1.5%10.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin70.8%72.5%72.5%72.5%
Operating margin16.6%24.7%26.3%25.4%
Net margin11.9%18.5%19.7%19.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings16.820.46.010.618.718.926.024.223.024.2
Price to sales2.32.11.52.74.24.65.34.34.45.5

Dividends and splits

Per share, in the currency the company pays

Paid for 37 years. Last went ex-dividend on 29 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year40.00120.0080.0077.0061.0055.5045.0045.00
  • 5-for-1 split · 29 Mar 2016

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.